Artia Global Partners LP Portfolio Holdings

Artia Global Partners LP

  • $395 Billion
  • Q1 2025

Artia Global Partners LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $395 Billion distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $78.4B, Soleno Therapeutics Inc with a value of $35.6B, Verona Pharma PLC with a value of $34.2B, Intra Cellular Therapies, Inc. with a value of $29B, and Insmed Inc with a value of $24.3B.

Examining the 13F form we can see an increase of $115B in the current position value, from $280B to 395B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $395 Billion
Healthcare: $342 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$725B
$78.4 Billion 19.84% of portfolio
94,887
Q1 2025 New
Soleno Therapeutics Inc
-
$35.6 Billion 9.01% of portfolio
-
Q1 2025 Added 0.82%
$5.66B
$34.2 Billion 8.65% of portfolio
538,488
Q1 2025 Added 110.91%
$12.4B
$29 Billion 7.34% of portfolio
219,719
Q4 2024 Added 1.48%
$13.9B
$24.3 Billion 6.14% of portfolio
318,239
Q1 2025 Added 89.5%
$2.44B
$17.9 Billion 4.52% of portfolio
424,640
Q1 2025 Reduced 8.45%
$2.61B
$16.1 Billion 4.09% of portfolio
333,851
Q1 2025 Added 13.61%
$2.76B
$15 Billion 3.8% of portfolio
229,085
Q1 2025 Reduced 0.3%
$217B
$14 Billion 3.55% of portfolio
190,752
Q2 2023 Added 86.45%
$145B
$13.1 Billion 3.31% of portfolio
129,700
Q1 2025 New
$15.6B
$9.6 Billion 2.43% of portfolio
56,717
Q1 2025 New
$38.1B
$7.72 Billion 1.95% of portfolio
28,600
Q1 2025 Reduced 49.29%
$30B
$6.69 Billion 1.69% of portfolio
11,311
Q4 2024 Reduced 25.28%
$3.22B
$6.44 Billion 1.63% of portfolio
90,745
Q1 2025 Reduced 55.53%
$1.76B
$5.54 Billion 1.4% of portfolio
172,185
Q1 2025 New
$3.48B
$3.68 Billion 0.93% of portfolio
104,190
Q1 2025 Reduced 63.34%
$2.93B
$2.38 Billion 0.6% of portfolio
53,930
Q1 2024 New
$1.99B
$2.18 Billion 0.55% of portfolio
90,279
Q4 2024 Reduced 83.06%
$584M
$2.16 Billion 0.55% of portfolio
160,000
Q1 2025 Added 60.0%
$5.23B
$2.15 Billion 0.54% of portfolio
54,515
Q4 2024 New
$180B
$1.73 Billion 0.44% of portfolio
3,500
Q1 2025 New
$290M
$1.72 Billion 0.43% of portfolio
316,700
Q1 2025 Added 46.15%
$12.1B
$1.63 Billion 0.41% of portfolio
14,700
Q1 2025 Reduced 67.33%
$13.2B
$1.54 Billion 0.39% of portfolio
5,000
Q1 2025 New
$2B
$1.34 Billion 0.34% of portfolio
40,000
Q1 2024 New
$9.87B
$1.16 Billion 0.29% of portfolio
7,440
Q2 2024 Reduced 53.19%
$983M
$1.03 Billion 0.26% of portfolio
38,100
Q1 2025 Reduced 76.62%
$351M
$948 Million 0.24% of portfolio
421,359
Q1 2024 New
$918M
$554 Million 0.14% of portfolio
30,900
Q1 2025 New
$1.2B
$507 Million 0.13% of portfolio
35,226
Q1 2025 Reduced 56.18%
Oruka Therapeutics Inc
-
$75.7 Million 0.02% of portfolio
-
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $395 Billion
  • Prior Value $280 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 8 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email